Azurity Pharmaceuticals, Inc.

Xatmep

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Azurity Pharmaceuticals, Inc.

Xatmep HCPCS:

J8612

HCPCS Code Descriptor:

Oral methotrexate (xatmep)

Category:

J Code

Xatmep NDCs:

52652-2001-01, 52652-2001-06

Primary Type:

Anti-Anemia

Generic/Specialty Status:

Single-Source

Package Type:

Oral solution in bottle

Route of Administration:

Oral

Xatmep CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Xatmep:

Xatmep is a medication manufactured by Azurity Pharmaceuticals, Inc. and aligned to the J Code: J8612. Xatmep is administered via the Oral route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J8612 Added Date:

1-Jul-24

J8612 Effective Date:

1-Jul-24

J8612 Termination Date:

HCPCS Active

Our team did not identify patient assistance information for Xatmep
Patient assistance information for Xatmep can be found through Azurity Solutions at the following URL: https://azuritysolutions.com/
Xatmep prescribing information can be found at the link below:
Our team did not identify a source of side effect information for Xatmep.